-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Exagen, Raises Price Target to $11

Benzinga·10/13/2026 16:09:16
語音播報
TD Cowen analyst Dan Bergstrom maintains Exagen (NASDAQ:XGN) with a Buy and raises the price target from $10 to $11.